Skip to main content
. 2017 May 2;18:80. doi: 10.1186/s12931-017-0564-3

Fig. 2.

Fig. 2

BCT-100 suppressed tumor growth and increased median survival in MPM xenograft models. BCT-100 inhibited tumor growth in a dose-dependent manner in (a) 211H and (b) H226 xenografts. BCT-100 (60 mg/kg) increased median survival in (c) 211H and (d) H226 xenograft models